Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression-Reference-Cited by-同舟云学术

Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression

Published:2011-05 Issue:2 Volume:304 Page:90-96
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ye Cai-Guo,Wu William Ka-Kei,Yeung John Hok-Keung,Li Hai-Tao,Li Zhi-Jie,Wong Clover Ching-Man,Ren Shun-Xiang,Zhang Lin,Fung Kwok-Pui,Cho Chi-Hin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Mechanisms of cancer drug resistance;Gottesman;Annu. Rev. Med.,2002

2. Relevance of multidrug resistance in the age of targeted therapy;Turk;Curr. Opin. Drug. Discov. Devel.,2009

3. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux;Tainton;Cell Death Differ.,2004

4. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies;Mimeault;Clin. Pharmacol. Ther.,2008

5. Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs;Sanchez;Prostate,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC;Hepatology Communications;2024-05

2. Chitosan – dextran phosphate carbamate hydrogels for locally controlled co-delivery of doxorubicin and indomethacin: From computation study to in vivo pharmacokinetics;International Journal of Biological Macromolecules;2023-02

3. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease;Heliyon;2022-06

4. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects;Drug Discovery Today;2022-02

5. HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway;Frontiers in Oncology;2021-10-27